Neuromodulation in the Treatment of Migraine: Progress in Nerve Stimulation
Journal Title: Neuro – Open Journal - Year 2016, Vol 3, Issue 1
Abstract
Migraine is a type of primary headache disorder that can become chronic and disabling. The exact pathomechanism of migraine is not known very well and its treatment is also difficult in some cases. There are several medications for the acute and preventive treatment of migraine including the “triptan” family drugs, nonsteroidal anti-inflammatory drugs, anti-epileptic drugs, beta-blockers, and Ca2+-channel blockers1 and those against calcitonin gene-related peptide or its receptor that are reviewed elsewhere.2 However, there are some medically intractable headaches or patient management is unsatisfactory or medications are poorly tolerated3 or there are contraindications. Therefore, neuromodulation and nerve stimulation methods that have proven effective in clinical research may provide an additional treatment option for acute and preventive treatment of migraine. In this brief review, we will discuss recent advances using neuromodulatory techniques that are used in the treatment of headaches in clinical studies. These include the electrical stimulation of occipital nerve, sphenopalatine ganglion, supraorbital nerve, and transcutaneous electrical stimulation of vagus nerve as well as singlepulse transcranial magnetic stimulation. Several clinical studies have conducted neurostimulation for the acute and preventive treatment of migraine in recent years but more studies are necessary to see their efficacy and long-term effect.
Authors and Affiliations
Mohtashem Samsam
Keywords
Related Articles
- EP ID EP552552
- DOI 10.17140/NOJ-3-122
- Views 152
- Downloads 0
Chronic Subdural Haematoma: Systematic Review Highlighting Risk Factors for Recurrent Bleeds
Introduction: Chronic subdural haematoma (CSDH) is one of the commonest forms of intracranial haemorrhage. Surgical drainage of CSDH is a routine operation in the modern neurosurgical practice which has shown to be the m...
Radiation Therapy and Nimotuzumab in Children and Adolescents with Brainstem Gliomas: A 5-Year Institutional Experience
Background: Brainstem gliomas (BSG) are Central Nervous System (CNS) tumors with a median survival time of approximately 9 months. Up to now chemotherapy has not shown to improve survival in these patients. The outcome o...
Adult Attention-Deficit and Hyperactivity Disorder and Fibromyalgia: A Case-Control Study
Introduction: Fibromyalgia syndrome (FMS) is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues. An association between attention deficit and fibromyalgia wa...
Wernicke Encephalopathy and Other Vitamin Deficiencies in a Patient with Home Parenteral Nutrition
Wernicke Encephalopathy (WE) is an acute and serious secondary neurological syndrome caused by a deficit of thiamine or vitamin B1. Although it rarely presents with the classic triad, the most frequent presenting symptom...
Immunomodulatory Effects of Mesenchymal Stem Cells on T- and B-Cells in a Quiescent State in a Chronic Experimental Model of Autoimmune Encephalomyelitis
Introduction: Multiple sclerosis (MS) is an immune-mediated disease affecting the central nervous system (CNS). Many drugs have been tested in animal models of MS (e.g., Experimental Autoimmune Encephalomyelitis (EAE))....